Literature DB >> 26019208

Mupirocin Resistance in Isolates of Staphylococcus spp. from Nasal Swabs in a Tertiary Hospital in France.

Sophie Trouillet-Assant1, Sacha Flammier2, Anais Sapin2, Céline Dupieux3, Oana Dumitrescu3, Anne Tristan3, François Vandenesch3, Jean-Philippe Rasigade3, Frederic Laurent3.   

Abstract

Mupirocin is a topical antibiotic largely used to eradicate staphylococcal nasal carriage. Here, we investigated the prevalence of mupirocin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates recovered from patients in different wards in a hospital (Lyon, France), which were determined both phenotypically with an Epsilometer test (Etest) and genetically by PCR for mupA and mupB.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26019208      PMCID： PMC4508416          DOI： 10.1128/JCM.00274-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Etienne Carbonnelle; Jean-Luc Beretti; Stéphanie Cottyn; Gilles Quesne; Patrick Berche; Xavier Nassif; Agnès Ferroni
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

2.  Ward-specific rates of nasal cocolonization with methicillin-susceptible and -resistant Staphylococcus spp. and potential impact on molecular methicillin-resistant Staphylococcus aureus screening tests.

Authors:  Sophie Trouillet-Assant; Jean-Philippe Rasigade; Sebastien Lustig; Yannick Lhoste; Florent Valour; Claude Guerin; Frederic Aubrun; Sylvestre Tigaud; Frederic Laurent
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.

Authors:  Julian G Hurdle; Alex J O'Neill; Lona Mody; Ian Chopra; Suzanne F Bradley
Journal:  J Antimicrob Chemother       Date:  2005-11-07       Impact factor: 5.790

4.  Mupirocin resistance is not an inevitable consequence of mupirocin use.

Authors:  D Talon; C Marion; M Thouverez; X Bertrand
Journal:  J Hosp Infect       Date:  2011-10-02       Impact factor: 3.926

5.  Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin.

Authors:  David J Hetem; H Charles Vogely; Tim T Severs; Annet Troelstra; Johannes G Kusters; Marc J M Bonten
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

Review 6.  The role of nasal carriage in Staphylococcus aureus infections.

Authors:  Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

7.  Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey.

Authors:  B Lamy; F Laurent; O Gallon; F Doucet-Populaire; J Etienne; J-W Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

8.  MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus.

Authors:  Christine Seah; David C Alexander; Lisa Louie; Andrew Simor; Donald E Low; Jean Longtin; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

9.  Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital.

Authors:  Hee-Jeong Yun; Sang Won Lee; Gyu Man Yoon; Su Yeon Kim; Sooyoung Choi; Yeong Seon Lee; Eung-Chil Choi; Sunghoon Kim
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

10.  Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals.

Authors:  E Petinaki; I Spiliopoulou; F Kontos; M Maniati; Z Bersos; N Stakias; H Malamou-Lada; Ch Koutsia-Carouzou; A N Maniatis
Journal:  J Antimicrob Chemother       Date:  2003-12-04       Impact factor: 5.790
View more
  4 in total

Review 1.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Staphylococcus epidermidis isolates from nares and prosthetic joint infections are mupirocin susceptible.

Authors:  Lavin Salih; Staffan Tevell; Emeli Månsson; Åsa Nilsdotter-Augustinsson; Bengt Hellmark; Bo Söderquist
Journal:  J Bone Jt Infect       Date:  2018-01-01

3.  Prevalence of Staphylococcus spp. nasal colonization among doctors of podiatric medicine and associated risk factors in Spain.

Authors:  Sheila de Benito; Luis Alou; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; María Luisa Gómez-Lus; Luis Collado; David Sevillano
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-17       Impact factor: 4.887

4.  Understanding the Virulence of Staphylococcus pseudintermedius: A Major Role of Pore-Forming Toxins.

Authors:  Yousef Maali; Cédric Badiou; Patrícia Martins-Simões; Elisabeth Hodille; Michele Bes; François Vandenesch; Gérard Lina; Alan Diot; Frederic Laurent; Sophie Trouillet-Assant
Journal:  Front Cell Infect Microbiol       Date:  2018-06-28       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.